---
schema_version: "secwatch.filing_event.v1"
accession: "0001420720-24-000029"
form_type: "8-K"
ticker: "IBIO"
cik: "0001420720"
company_name: "iBio, Inc."
filed_at: "2024-07-09T23:59:59+00:00"
generated_at: "2026-05-31T22:33:05.241639+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# iBio adopts standard equity award forms and updates Code of Business Conduct

## Summary
- Board approved forms of stock option and RSU agreements for directors, officers, employees, and consultants under the 2023 Plan.
- Award agreements include provisions for exercise price payment methods, vesting schedules, and termination treatment.
- Updated Code of Business Conduct and Ethics to modernize language and enhance risk mitigation.
- No executive departures, new appointments, or financial guidance changes were disclosed.
- Actions are routine governance updates with no immediate material financial impact.

## SEC filing metadata
- accession: 0001420720-24-000029
- form_type: 8-K
- ticker: IBIO
- cik: 0001420720
- company_name: iBio, Inc.
- filed_at: 2024-07-09T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 5.02, 5.05, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1420720/000142072024000029/0001420720-24-000029-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1420720/000142072024000029/ibio-20240702x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001420720-24-000029
- JSON: https://secwatch.observer/filing/0001420720-24-000029.json
- Plain text: https://secwatch.observer/filing/0001420720-24-000029.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.